Finance

Rocket Lab stock jumped about 5% after its 21st Electron launch, delivering the QPS-SAR-15 satellite for Japan’s iQPS into orbit from New Zealand. The milestone caps a 2025 streak where every mission hit its target, reinforcing Electron’s status as the busiest small-lift rocket. With the Electron Launch Series complete, the company is already eyeing a…

Old National Bancorp is navigating a high-stakes legal battle while its stock rides a wave of growth optimism. With solid earnings potential shadowed by loan-growth and real estate risks, the valuation debate is far from settled.

Citadel has more than doubled its stake in D-Wave Quantum, signaling rising institutional bets on the quantum frontier. With D-Wave pushing practical quantum annealing amid lofty valuations and mixed profitability, this development adds another layer to a high-stakes space worth watching.

Alibaba’s stock is catching a fresh wave of optimism as AI and cloud initiatives accelerate growth. Analysts remain upbeat despite near-term challenges, signaling a potential rebound driven by cloud leadership and AI monetization—a development that could reshape the stock’s trajectory in the months ahead.

A data analytics powerhouse is leaning into AI and cloud-scale upgrades to reshape its growth path. With the OneTru platform expanding and stronger fraud-prevention capabilities, the story hints at meaningful upside ahead.

Gold and silver have shined this year, but the big questions loom for 2026. With silver emerging as a rare leader for gold and prices riding a sharp, parabolic ascent, what could the coming months hold for these precious metals?

Once celebrated as a beacon of LA wealth, a billionaire’s glittering empire hides a tangled web of debt. Homes, art, and philanthropy collide with a looming court battle over assets and liquidity. A tale that asks: how lasting is fortune built on leverage and illusion?

Micron has sprinted to fresh highs, yet sentiment is cooling as earnings loom. In a market wary of high-growth tech, the next results could redefine the stock’s path.

McKesson delivered a solid quarter with an earnings beat and steady revenue growth, while major investors expanded their positions. The stock has climbed near recent highs as institutions pile in and the dividend remains in the spotlight. With a buoyant analyst outlook and rising price targets, the healthcare leader is capturing renewed market attention.

Lloyds Banking Group slipped as investors weighed motor-finance mis-selling headwinds and a seasonal lull in trading. Yet behind the volatility, the bank’s solid earnings and strategic moves point to a resilient longer-term outlook.

Lloyds Banking Group has sparked a powerful rally, outpacing the market over the last year. Yet with the stock trading near analysts’ implied fair value, investors are weighing whether the run still has room to run—or if risk is already baked in. A contrasting valuation view hints at hidden upside, while economic headwinds and digital…

Ford’s stock has moved sharply, but what does that say about its true value? A fresh valuation take blends traditional metrics with a personal-fair-value lens, weighing EV momentum against legacy strength and the road ahead.

Rivian faces a cooling EV market even as it rolls out bold tech bets. The company previewed autonomy upgrades, including custom chips and new car computers, plus an Autonomy+ plan tied to its next-gen models. With rising competition and shifting demand, the path forward looks intriguing and unscripted.

Pfizer is pursuing a dual-track strategy, tying an exclusive partnership to advance YP05002, an oral GLP-1 obesity drug, while unveiling promising Phase 3 data for TUKYSA in HER2-positive metastatic breast cancer. A look at how these moves could shape the company’s growth in a shifting healthcare landscape.

Tilray Brands sparks a notable rally as whispers swirl about a possible easing of federal cannabis restrictions. A shift like a reclassification could cut red tape, open up research opportunities, and reshape the investment landscape for cannabis companies. With market volatility and policy chatter heating up, the sector may be at a pivotal turning point.

Data analytics stocks delivered a mixed Q3, with an AI-driven platform capturing attention while peers posted varied results and sharp stock swings. With rate cuts reshaping markets and policy questions ahead, the sector’s next move remains intriguing.

Cathie Wood’s ARK Invest is reshuffling its bets, trimming tech and communications exposure while loading up on biotechnology across several ARK ETFs. The shift hints at a bold strategic pivot and could redefine the fund’s growth story in healthcare innovation.

Elon Musk hasturned a multi‑billion fortune into something almost unimaginable, driven by Tesla’s surge and bold bets on the future. A record pay package and a clutch of ambitious projects hint at what might come next on a path toward wealth that defies imagination.

Mortgage rates edged higher on Friday, bucking the recent rate-cut move. The gap between short-term Fed policy and long-term home loans comes down to different timeframes and daily market swings. With key reports on Retail Sales, CPI, and jobs ahead, the next moves remain highly uncertain.

Rocket Lab moves a high-priority Earth-imaging mission into its launch slate, signaling a faster path to rapid-response satellites. The scheduling shift has investors watching as the program expands toward disaster monitoring and environmental surveillance from space.

Vietnam’s stock market closed under pressure as heavyweight stocks and real estate names led a broad sell-off, pushing the VN-Index below key support levels. With volatility set to persist and investors weighing a potential rebound against further downside, the next moves could shape the near-term outlook.